You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Interleukin-8 (IL-8)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Periodontitis Trial in Rize (biochemical analysis)

Completed
  • Periodontitis
  • biochemical analysis
  • Rize, Turkey
    Recep Tayyip Erdogan University
Oct 18, 2023

Serum Interleukin 6 and 8 in Children With Acute Gastroenteritis

Recruiting
  • Acute Gastroenteritis
  • Acute Diarrhea
  • Evaluation of serum levels of IL-6 and IL-8
  • Sohag, Egypt
    Sohag University Hospital
Jan 15, 2022

Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Atlanta (Aldesleukin,

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Aldesleukin
  • Pembrolizumab
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Aug 8, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial in

Not yet recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Biospecimen Collection
  • +8 more
  • Kansas City, Kansas
    University of Kansas Cancer Center
Nov 27, 2023

Nitrates and IL-8 in Barrett's Esophagus

Enrolling by invitation
  • Barrett Esophagus
  • Esophageal Adenocarcinoma
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Mar 31, 2022

    COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)

    Active, not recruiting
    • COL6A3 Positive
    • +3 more
    • Aldesleukin
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 22, 2022

    Solid Tumor, Sars-CoV2, Hematological Malignancy Trial in New York (BMS-986253)

    Terminated
    • Solid Tumor
    • +2 more
    • New York, New York
      Columbia University Irving Medical Center
    Nov 18, 2021

    Idiopathic Multicentric Castleman's Disease Trial in Beijing, Chengdu (Recombinant Humanized Anti-interleukin-6 Receptor

    Recruiting
    • Idiopathic Multicentric Castleman's Disease
    • Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 4mg/kg
    • +2 more
    • Beijing, China
    • +2 more
    Apr 26, 2022

    Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+

    Active, not recruiting
    • Metastatic Malignant Neoplasm in the Liver
    • Metastatic Uveal Melanoma
    • Aldesleukin
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 20, 2023

    Intracerebral Haemorrhage Trial in Manchester (IL-1Ra Kineret®, IL-1Ra Placebo)

    Completed
    • Intracerebral Haemorrhage
    • IL-1Ra Kineret®
    • IL-1Ra Placebo
    • Manchester, North West, United Kingdom
      Salford Royal NHS Foundation Trust
    Oct 4, 2021

    Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma Trial in

    Recruiting
    • Advanced Bladder Urothelial Carcinoma
    • +23 more
    • Riverside, California
    • +8 more
    Jul 16, 2022

    Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

    Active, not recruiting
    • Platinum-Resistant Fallopian Tube Carcinoma
    • +11 more
    • Aldesleukin
    • +3 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 13, 2022

    Metastatic Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston (biological, drug, other)

    Active, not recruiting
    • Metastatic Melanoma
    • Stage IV Cutaneous Melanoma AJCC v6 and v7
    • Aldesleukin
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 2, 2022

    Amyotrophic Lateral Sclerosis Trial in France, United Kingdom (Riluzole, IL-2, 5% glucose water solution)

    Completed
    • Amyotrophic Lateral Sclerosis
    • Lille, France
    • +16 more
    Apr 1, 2022

    Acute Myeloid Leukemia, EBV-Positive Neoplastic Cells Present, HLA-A*0201 Positive Cells Present Trial in Seattle (Aldesleukin,

    Terminated
    Has Results
    • Acute Myeloid Leukemia
    • +4 more
    • Aldesleukin
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 15, 2021

    PCO Trial in Peshawar (OLIVE OIL 5ML/5MG (BD) NUTRITIONAL SACHET 2100MG (BD), Metformin (1000 mg Twice a day))

    Recruiting
    • PCO
    • OLIVE OIL 5ML/5MG (BD) NUTRITIONAL SACHET 2100MG (BD)
    • Metformin (1000 mg Twice a day)
    • Peshawar, Khyber Pakhtunkhwa, Pakistan
      Gynecology and Obstetric, Hayatabad Medical Complex
    Jul 19, 2023

    Subarachnoid Hemorrhage Trial in United Kingdom (IL-1Ra, IL-1Ra Placebo)

    Recruiting
    • Subarachnoid Hemorrhage
    • Plymouth, Devon, United Kingdom
    • +11 more
    May 16, 2022

    Endodontically Treated Teeth Trial in Cairo (Intracanal Diode laser irradiation, Placebo)

    Completed
    • Endodontically Treated Teeth
    • Intracanal Diode laser irradiation
    • Placebo
    • Cairo, Egypt
      Faculty of Dentistry
    Nov 15, 2022

    Apical Periodontitis Trial in Giza (Root canal instrumentation, 2.5% NaOCl irrigation)

    Completed
    • Apical Periodontitis
    • Root canal instrumentation, 2.5% NaOCl irrigation
    • Giza, Egypt
      Faculty of Dentistry, Cairo University
    Jan 18, 2023

    HLA-A*0201 Positive Cells Present, NY-ESO-1 Positive Tumor Cells Present, Recurrent Myxoid Liposarcoma Trial in Houston

    Active, not recruiting
    • HLA-A*0201 Positive Cells Present
    • +3 more
    • Aldesleukin
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 25, 2022

    Clinical Stage IV Gastric Cancer AJCC v8, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Rochester

    Not yet recruiting
    • Clinical Stage IV Gastric Cancer AJCC v8
    • +4 more
    • Aldesleukin
    • +10 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Apr 5, 2023

    Head and Neck Tumors Trial (TransCon TLR7/8 Agonist, Pembrolizumab, TransCon IL-2 ß/?)

    Not yet recruiting
    • Head and Neck Neoplasms
    • TransCon TLR7/8 Agonist
    • +2 more
    • (no location specified)
    Aug 4, 2023

    IL6&8 in Malnourished Children With Acute Diarrhea

    Not yet recruiting
    • Acute Diarrhea
    • +2 more
    • Evaluation of serum levels of IL-6 and IL-8
    • Sohag, Egypt
      Sohag University Hospital
    Dec 21, 2021

    Symptomatic Irreversible Pulpitis Trial (Prednisolone 30 mg, Diclofenac Potassium 50mg Tab, Placebo)

    Unknown status
    • Symptomatic Irreversible Pulpitis
    • Prednisolone 30 mg
    • +2 more
    • (no location specified)
    Oct 25, 2020

    Glioblastoma Trial in Gainesville (Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells)

    Not yet recruiting
    • Glioblastoma
    • Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells
    • Gainesville, Florida
      University of Florida Health
    Jul 29, 2022